Loading ......
Measles is a highly contagious viral disease that poses a significant public health threat worldwide. The measles virus (MeV) is responsible for the infection and primarily targets the respiratory system, causing symptoms such as fever, cough, runny nose, and a characteristic rash. In severe cases, measles can lead to complications such as pneumonia, encephalitis, and even death, particularly in young children and individuals with compromised immune systems.
The successful entry and infection of the MeV into host cells are mediated by the interaction between the viral hemagglutinin (H) protein and specific cell surface receptors. Understanding the mechanisms underlying the interaction between the MeV H protein and host cell receptors is essential for developing effective strategies to combat measles infection.
MeV is a paramyxovirus with a non-segmented RNA genome that encodes various proteins, including nucleocapsid protein (NP), virulence factors (C and V), phosphoprotein (P), matrix protein (M), hemagglutinin (H), membrane fusion protein (F), and RNA-dependent RNA polymerase (L). MeV is enveloped and contains two viral glycoproteins, H and F, on its membrane. The H and F proteins form a hetero-oligomer that is essential for inducing membrane fusion. Upon binding to its receptor, the H protein undergoes a conformational change, leading to a structural rearrangement of the F protein. This rearrangement occurs from the metastable pre-fusion form to the intermediate and post-fusion forms. These changes facilitate the fusion of the viral envelope with the host cell membrane, allowing the virus to enter the cell. During this process, the binding of H protein to cell receptors is the initial event of infection. The attachment of H to its host receptor triggers the fusion of the F protein between the virus and the host cell membrane.
MeV infects humans and certain monkey species but not rodents. MeV was initially isolated and adapted to grow in laboratory primate cell lines. In 1954, a strain called the Edmonston strain was isolated from a patient and later adapted to grow in monkey kidney cell lines. It was further passaged in chick embryo fibroblasts to produce the first attenuated MeV vaccine. Tissue-culture-cell-adapted virus isolates could agglutinate the red blood cells of old world monkeys but not humans. The laboratory-adapted Edmonston strain of MeV played a crucial role in understanding its molecular properties. One of the viral membrane glycoproteins was identified as the hemagglutinin (H) protein, responsible for hemagglutination.
The H protein's gene was cloned in 1986, and its sequence was reported. The H protein is a type II glycoprotein with 617 amino acids and contains multiple glycosylation sites. Structural studies using X-ray crystallography have revealed that the H protein consists of an α-helical stalk supporting a six-blade β-propeller head structure. The H protein forms disulfide-linked dimers and tetramers on the viral surface. It works in association with the fusion (F) protein to activate fusion during viral entry and cell-to-cell transmission. The binding of the H protein to its receptors triggers conformational changes in the F protein, leading to fusion and viral entry. Studying these molecular properties of the H protein is crucial for understanding MeV pathogenesis and developing interventions against infection.
Figure 1. Structure of the head region from the hemagglutinin (H) protein of MeV.
(Source: Lin, L. T. et al., 2016)
MeV receptors play a critical role in the viral entry process, allowing the virus to attach to and enter host cells. Three protein molecules have been identified as MeV receptors, CD46, the signaling lymphocyte activation molecule (SLAM), and nectin-4.
It's important to note that the usage of these receptors by MeV can vary depending on the viral strain, viral adaptation, and cell type. The receptor repertoire of MeV highlights its ability to infect a wide range of cell types, contributing to the systemic and respiratory manifestations observed in measles infections.
Understanding the specific interactions between MeV and its receptors, including CD46, SLAM, and nectin-4, provides insights into viral tropism, pathogenesis, and potential targets for therapeutic interventions and vaccine development. Ongoing research continues to explore the intricate details of MeV receptor usage to enhance our understanding of this viral infection.
References
| Target | Cat. No. | Product Name | Size | Species Reactivity | Application | Detection Sample | |
| MeV | DEIABL354 | Measles Virus IgM ELISA Kit | 96T | Human | Qualitative | Serum or plasma (citrate, heparin) | Inquiry |
| DEIA359 | Measles Virus IgG ELISA Kit | 96T | Human | Qualitative | Serum, Plasma, (citrate, heparin) | Inquiry | |
| DEIA360 | Measles IgA ELISA Kit | 96T | Human | Quantitative | serum, plasma | Inquiry | |
| DEIA361 | Measles IgM ELISA Kit | 96T | Human | Quantitative | serum, plasma | Inquiry | |
| DEIA8265 | Human MV-IgG(Measles virus-Immunoglobulin G) ELISA Kit | 96T | Human | Quantitative | Serum or plasma | Inquiry | |
| SLAMF1 | ABPR-ZB096 | Human SLAM/CD150 Antibody Pair Set | 5 Plates, 15 Plates | Human | sELISA | Inquiry | |
| PVRL4 | DEIABL667 | Human Nectin-4/PVRL4 ELISA Kit | 96T | Quantitative | cell culture supernates, serum, heparin plasma, EDTA plasma, cell lysates, urine | Inquiry |
Loading ......